Baylx Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis (NCT03828344) | Baylx Inc. | 2026-12-01 |
| Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS (NCT04452097) | Baylx Inc. | 2026-06-01 |
Track Baylx Inc. automatically
Every clearance here is in the API, with alerts when new ones post.